Craft

OraSure Technologies

Stock Price

$4.3

2024-10-29

Market Capitalization

$317.7 M

2024-10-29

Revenue

$405.5 M

FY, 2023

OraSure Technologies Summary

Company Summary

Overview
OraSure Technologies is a company providing diagnostics and testing solutions and services. It is engaged in the development, manufacture, and distribution of diagnostic products and specimen collection devices, as well as immunoassays and in vitro diagnostic tests used for the detection of various diseases including COVID-19, HIV, and hepatitis C. The company also provides tests for drugs of abuse.
Type
Public
Status
Active
Founded
1987
HQ
Bethlehem, PA, US | view all locations
Website
https://www.orasure.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Carrie Eglinton Manner

    Carrie Eglinton Manner, President & Chief Executive Officer, Director

  • Michele Anthony

    Michele Anthony, Senior Vice President, Controller & Chief Accounting Officer

  • Kenneth J. McGrath

    Kenneth J. McGrath, Chief Financial Officer

  • Kathleen Weber

    Kathleen Weber, Chief Product Officer

Operating MetricsView all

Business Segments

2

FY, 2022

Facility Space Owned, sq. ft.

113.2K

FY, 2022

Facilities Leased, sq. ft.

244.9K
21.3%

FY, 2022

LocationsView all

5 locations detected

  • Bethlehem, PA HQ

    United States

    220 E 1st St

  • Bethlehem, PA

    United States

    150 Webster St

  • Bethlehem, PA

    United States

    1745 Eaton Ave

  • Bethlehem, PA

    United States

    2500 Emrick Blvd #100

  • Bethlehem, PA

    United States

    2685 Opus Way #100

OraSure Technologies Financials

Summary Financials

Revenue (Q3, 2024)
$39.9M
Gross profit (Q3, 2024)
$17.1M
Net income (Q3, 2024)
($4.5M)
Cash (Q3, 2024)
$278.6M
EBIT (Q3, 2024)
($6.0M)
Enterprise value
$40.7M

Footer menu